Novel approach to pain recognised with NHMRC Marshall and Warren Award

ARCHIVED CONTENT – For reference purposes only

Summary media release information

30 October 2013
NHMRC Media Release
Contact for further information: 
NHMRC Media Team: 0422 008 512

A researcher whose work challenges our understanding of pain has been awarded the National Health and Medical Research Council’s 2012 Marshall and Warren Award.

NHMRC has recognised University of South Australia Professor Lorimer Moseley for research that could help uncover more effective solutions for treating acute pain and prevent it from developing into chronic pain.

“The Marshall and Warren Award acknowledges innovative research that may otherwise have difficulty attracting funding because it goes against prevailing ideas,” NHMRC CEO Professor Warwick Anderson said.

NHMRC established the award in honour of Professors Barry Marshall and Robin Warren who won the Nobel Prize for Physiology or Medicine in 2006 for their discovery that the bacterium Helicobacter pylori is the cause of most peptic ulcers.

Their findings, which subverted conventional wisdom, resulted in the development of an effective treatment for peptic ulcers.”

“Professor Moseley’s research breaks new ground on our understanding of how our brains process an experience of pain. His research indicates that whether a person will suffer from chronic pain is unrelated to the type or extent of their injury,” Professor Anderson said.

Professor Moseley’s research suggests that chronic pain occurs when our brains encode our experience of pain resulting from injury incorrectly. This can lead to pain prevailing long after the injury has healed, and may even cause pain to be felt in areas of the body unaffected by the initial injury.

“NHMRC is proud to support Professor Moseley as he works to identify those at high-risk of developing chronic pain after an injury and develop and test new treatments for the prevention and management of chronic pain,” Professor Anderson said.

Media Contact 

NHMRC Media Team: 0422 008 512